Carbamazepine

Dosage ;

Usual Dose = 100-1600 mg daily.

Children: 10-20mg/kg daily depending on severity of illness and indication.

A tricyclic iminostilbene derivative

Specific Dosages;

Dosing: Adult

Dosage must be adjusted according to patient's response and serum concentrations. Administer tablets (chewable or conventional) in 2-3 divided doses daily and suspension in 4 divided doses daily. Oral:

Epilepsy: Initial: 400 mg/day in 2 divided doses (tablets or extended release tablets) or 4 divided doses (oral suspension); increase by up to 200 mg/day at weekly intervals using a twice daily regimen of extended release tablets or capsules, or a 3-4 times/day regimen of other formulations until optimal response and therapeutic levels are achieved; usual dose: 800-1200 mg/day

Maximum recommended dose: 1600 mg/day; however, some patients have required up to 1.6-2.4 g/day

Trigeminal or glossopharyngeal neuralgia: Initial: 200 mg/day in 2 divided doses (tablets, extended release tablets, or extended release capsules) or 4 divided doses (oral suspension) with food, gradually increasing in increments of 200 mg/day as needed.

Maintenance: Usual: 400-800 mg daily in 2 divided doses (tablets, extended release tablets, or extended release capsules) or 4 divided doses (oral suspension); maximum dose: 1200 mg/day

Bipolar disorder: Initial: 400 mg/day in 2 divided doses (tablets, extended release tablets, or extended release capsules) or 4 divided doses (oral suspension), may adjust by 200 mg/day increments; maximum dose: 1600 mg/day.

Dosing: Pediatric

Dosage must be adjusted according to patient's response and serum concentrations. Administer tablets (chewable or conventional) in 2-3 divided doses daily and suspension in 4 divided doses daily.

Epilepsy: Oral:

Children <6 years: Initial: 10-20 mg/kg/day divided twice or 3 times daily as tablets or 4 times/day as suspension; increase dose every week until optimal response and therapeutic levels are achieved

Maintenance dose: Divide into 3-4 doses daily (tablets or suspension); maximum recommended dose: 35 mg/kg/day

Children 6-12 years: Initial: 200 mg/day in 2 divided doses (tablets or extended release tablets) or 4 divided doses (oral suspension); increase by up to 100 mg/day at weekly intervals using a twice daily regimen of extended release tablets or 3-4 times daily regimen of other formulations until optimal response and therapeutic levels are achieved

Maintenance: Usual: 400-800 mg/day; maximum recommended dose: 1000 mg/day

Note: Children <12 years who receive ≥400 mg/day of carbamazepine may be converted to extended release capsules (Carbatrol®) using the same total daily dosage divided twice daily

Children >12 years: Refer to adult dosing.

Maximum recommended doses:

Children 12-15 years: 1000 mg/day

Children >15 years: 1200 mg/day

Dosing: Geriatric

Refer to adult dosing.

Dosing: Renal Impairment

Dosage adjustments are not required or recommended in the manufacturer’s labeling; however, the following guidelines have been used by some clinicians (Aronoff, 2007):

Children and Adults:

GFR <10 mL/minute: Administer 75% of dose.

Hemodialysis, peritoneal dialysis: Administer 75% of dose.

Continuous renal replacement therapy (CRRT):

Children: Administer 75% of dose.

Adults: No dosage adjustment recommended.

Dosing: Hepatic Impairment

Use with caution in hepatic impairment; metabolized primarily in the liver

Carbamazepine Brands
Brand Name Manufacturer Name Distributor Drug Strength Packaging Formulation Formulation Strength Price
Azepine Biodeal Laboratories Ltd. Biodeal Laboratories Ltd. 200mg 100 Tablet per tablet KES 200.00
Azepine Biodeal Laboratories Ltd. Biodeal Laboratories Ltd. 200mg 1000 Tablet per tablet KES 1,700.00
Azepine Biodeal Laboratories Ltd. Biodeal Laboratories Ltd. 200mg 500 Tablet per tablet KES 1,000.00
Carbamazepine Torrent Pharmaceuticals Ltd. Medox Pharmaceuticals Ltd. 200mg 100 Tablet per tablet KES 200
Carbamazepine Torrent Pharmaceuticals Ltd. Medox Pharmaceuticals Ltd. 200mg 1000 Tablet per tablet KES 1,400
Carbatol Torrent Pharmaceuticals Ltd. Medox Pharmaceuticals Ltd. 200mg 100 Tablet per tablet KES 270.00
Carbatol Torrent Pharmaceuticals Ltd. Medox Pharmaceuticals Ltd. 200mg 1000 Tablet per tablet KES 2,650.00
Carbazin Eskayef Bangladesh Limited Umoja Pharmaceutical s Limited. 200mg 50 Tablet per tablet KES 1,351.00
Carbazina Flamingo Heat Pad Harley's Limited 200mg 100 Tablet per tablet KES 225.00
Carbazina Flamingo Heat Pad Harley's Limited 200mg 1000 Tablet per tablet KES 1,200.00
Eptol Cosmos Limited. Cosmos Limited 200mg 100 Tablet per tablet KES 450.00
Labtol Laboratory & Allied Ltd. Laboratory & Allied Ltd 200mg 1000 Tablet per tablet KES 1,800.00
Neurotrol Universal Pharmaceuticals Ltd. Europa Healthcare Ltd. 200mg 100 Tablet per tablet KES 228.00
Neurotrol Universal Pharmaceuticals Ltd. Europa Healthcare Ltd. 200mg 1000 Tablet per tablet KES 2,070.00
Taver Medochemie Omaera Pharmaceuticals Ltd 200mg 50 Tablet per tablet KES 250.00
Tegretol Novartis Consumers Harley's Limited 100mg 50 Tablet per tablet KES 1,092.30
Tegretol Novartis Consumers Harley's Limited 200mg 50 Tablet per tablet KES 1,684.00
Tegretol Novartis Consumers Harley's Limited 200mg 500 Tablet per tablet KES 12,521.00
Tegretol Novartis Consumers Harley's Limited 200mg 50 Tablet per tablet KES 1,684.00
Tegretol Novartis Consumers Harley's Limited 400mg 30 Tablet per tablet KES 1,755.00
Tegretol Novartis Consumers Harley's Limited 20mg 100ml Syrup per 5ML KES 820.00
Tegretol Novartis Consumers Harley's Limited 2mg 100ml Syrup per 5ML KES 653.00
Zen Intas Pharmaceuticals Ltd Unicorn Pharma (K) Ltd. 200mg 1000 Tablet per tablet KES 2,000.00
Zeptol Sunlight International Trading (Africa) Co., Ltd Harley's Limited 200mg 100 Tablet per tablet KES 1,360.00
Progretaz Prism Life Sciences Galaxy Pharmaceuticals Ltd 200mg 100 Tablet per tablet KES 210.00

Carbamazepine More info
Mode Of Action

Carbamazepine: Anticonvulsant action - the exact mechanism is unknown and possibilities may include: acting postsynaptically by limiting the ability of neurons to sustain high frequency repetitive firing of action potentials through enhancement of sodium channel inactivation, altering neuronal excitability, blocking the release of neurotransmitter by blocking presynaptic sodium channels and the firing of action potentials, which in turn decreases synaptic transmission. Antineuralgic - the exact mechanism is unknown and possibilities may include; involvement of gamma-aminobutyric acid (GABA) receptors, which may be linked to calcium channels.Antidiuretic: the exact mechanism is unknown and possibilities may include: exerting a hypothalamic effect on the osmoreceptors mediated via secretion of antidiuretic hormone (ADH), direct effect on the renal tubule.

Drug Indication All forms of epilepsy except absence seizures; prophylaxis in maniac depressive disorders in patients who are unresponsive to, or cannot tolerate lithium or neuroleptics alone; in alcohol withdrawal syndrome; trigeminal neuralgia; idiopathic glossopharyngeal neuralgia; diabetic neuropathy and diabetes insipidus.
Precautions Not to be used in absence seizures; in case of cardiac, hepatic and renal damage; monitor liver functions.
Contra-Indications History of bone marrow depression; hypersensitivity to carbamazepine and tricyclic anti-depressants; concomitant use with MAO inhibitors
Side Effects Dizziness; water retention and dilutional hyponatremia (due to induced stimulation of ADH); ataxia; GIT disturbances; drowsiness; headache; visual disturbances; anorexia; constipation; erythematous rashes; blood disorders; Steven-Johnson Syndrome; alopecia.
Dosage 100-1600 mg daily. Children: 10-20mg/kg daily depending on severity of illness and indication.
Special Information A tricyclic iminostilbene derivative
Pregnancy Category Category D
Pregnancy Category Description Drugs, which have caused, are suspected to have caused, or may be expected to cause an increased rise in the frequency of malformations or irreversible damage. These drugs may also have adverse pharmacological effects required required
Drug Category DRUGS ACTING ON CNS
Drug Sub-Category Anticonvulsants